Skip to main content Accessibility help
  • Print publication year: 2005
  • Online publication date: September 2009

3 - Metabolic acidosis


Metabolic acidosis is a common presenting or coincident feature of many inherited metabolic diseases. In some cases, the acidosis is persistent, though so mild that the generally recognized clinical signs, such as tachypnea, are absent or so subtle that they are missed. In other cases, the patient presents with an episode of acute, severe, even life-threatening, acidosis, and the underlying persistence of the condition is only recognized after resolution of the acute episode. Diagnostically, the most frustrating presentation is infrequent bouts of recurrent, acute acidosis separated by long intervals of apparent good health during which diagnostic tests show no significant abnormality. This is a particularly challenging situation.

Buffers, ventilation, and the kidney

The hydrogen ion concentration, [H+], of body fluids is maintained within very narrow limits by a combination of buffers, acting immediately, pulmonary ventilation to restore the capacity of blood buffers, and renal mechanisms to eliminate excess H+.

Quantitatively, the most important buffers in blood are the proteins, both the plasma proteins and hemoglobin. Alterations in the concentrations of these proteins, particularly hemoglobin, may seriously compromise the capacity of the body to cope with sudden accumulation of acid. The buffering contributed by the equilibrium between HCO3 and H2CO3 is important because the capacity of the system is rapidly restored by elimination of H2CO3 through conversion to CO2 and expulsion of the excess CO2 by increased pulmonary ventilation.

Fall, P. J. (2000). A stepwise approach to acid-base disorders. Practical patient evaluation for metabolic acidosis and other conditions. Postgraduate Medicine, 107, 249–50, 253–4, 257–8 passim.
Goldstein, M. B., Bear, R., Richardson, R. M. A., Marsden, P. A. & Halperin, M. L. (1986). The urine anion gap: a clinically useful index of ammonium excretion. American Journal of Medical Science, 292, 198–202.
Lehotay, D. & Clarke, J. T. R. (1995). Organic acidurias and related abnormalities. Critical Reviews in Clinical Laboratory Sciences, 32, 377–429.
Mitchell, G. A., Kassovska-Bratinova, S., Boukaftane, Y., et al. (1995). Medical aspects of ketone body metabolism. Clinical and Investigative Medicine, 18, 193–216.
Niaudet, P. & Rotig, A. (1996). Renal involvement in mitochondrial cytopathies. Pediatric Nephrology, 10, 368–73.
Ogier de Baulny, H. & Saudubray, J. M. (2002). Branched-chain organic acidurias. Seminars in Neonatology, 7, 65–74.
Rabier, D., Bardet, J., Parvy, Ph., et al. (1995). Do criteria exist from urinary organic acids to distinguish β-oxidation defects?Journal of Inherited Metabolic Diseases, 18, 257–60.
Rotig, A. (2003). Renal disease and mitochondrial genetics. Journal of Nephrology, 16, 286–92.
Stacpoole, P. W. (1997). Lactic acidosis and other mitochondrial disorders. Metabolism, 46, 306–21.
Thorburn, D. R. & Dahl, H. H. (2001). Mitochondrial disorders: genetics, counseling, prenatal diagnosis and reproductive options. American Journal of Medical Genetics, 106, 102–14.
Uribarri, J., Oh, M. S. & Carroll, H. J. (1998). D-lactic acidosis. A review of clinical presentation, biochemical features, and pathophysiologic mechanisms. Medicine (Baltimore), 77, 73–82.